N-GENE RESEARCH LABORATORIES, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 4251

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0000,809 USE OF BGP15 TO TREAT FAMILIAL DYSAUTONOMIAJun 29, 17Jan 04, 18[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8048873 Synergistic pharmaceutical combination for the prevention or treatment of diabetesNov 06, 09Nov 01, 11[A61K, A61P]
7763601 Prevention and treatment of obesityMar 19, 07Jul 27, 10[A61K, A61P]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0366,852 Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic MedicationAbandonedJun 23, 15Dec 24, 15[A61K]
2010/0311,719 Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic MedicationAbandonedAug 17, 10Dec 09, 10[A61K, A61P]
7767694 Pharmaceutical composition having prokinetic effectExpiredFeb 05, 09Aug 03, 10[A61K]
7635674 Synergistic pharmaceutical combination for the prevention or treatment of diabetesExpiredJul 10, 02Dec 22, 09[A61K]
2009/0281,143 Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or ObesityAbandonedDec 10, 08Nov 12, 09[A61K, A61P]
2009/0054,487 Pharmaceutical composition for increasing the mitochondrial genesisAbandonedJun 13, 05Feb 26, 09[A61K, C07D]
2008/0108,602 Prevention of obesity in antipsychotic, antidepressant and antiepileptic medicationAbandonedMar 19, 07May 08, 08[A61K, A61P]
2007/0281,972 Pharmaceutical Composition Having Prokinetic EffectAbandonedJun 13, 05Dec 06, 07[A61K, A61P]
2007/0243,596 Simultaneous Desizing and Scouring ProcessAbandonedJun 14, 05Oct 18, 07[C12N, D06M]
7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the sameExpiredMar 21, 05Dec 19, 06[C07D]
6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the sameExpiredMar 13, 01May 03, 05[A61K, A01N]
6884424 Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlightExpiredDec 07, 01Apr 26, 05[A61K, A01N]
6838469 Pharmaceutical composition that exhibits reduced side-effects comprising O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime and a pyrimidine derivative with known antitumor activityExpiredFeb 28, 02Jan 04, 05[A61K]
6720337 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivativeExpiredMar 27, 02Apr 13, 04[A61K]
6656955 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivativeExpiredFeb 28, 02Dec 02, 03[A61K]
6500823 Unsaturated hydroximic acid derivatives as per abstract inhibitorsExpiredMar 02, 01Dec 31, 02[C07D, C07C]
6458371 Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skinExpiredDec 04, 98Oct 01, 02[A61K, A01N]
6451851 Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agentExpiredMar 23, 00Sep 17, 02[A61K]
6440998 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivativeExpiredFeb 17, 00Aug 27, 02[A61K]
6306878 Pharmaceutical compositions containing hydroximic acid derivativesExpiredSep 27, 96Oct 23, 01[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.